Evidence map›Paper›PMID 40100569›Full record

ArticlePhysical and engineering sciences in medicine2025

Characteristics of the electron beam outside the applicator in an Elekta Versa HD Linac.

Kapil Dev Maharaj, Simon Goodall, Mahsheed Sabet, Joshua Dass, Mounir Ibrahim, Talat Mahmood, Pejman Rowshanfarzad

Abstract read
In one paragraph

Article in Physical and engineering sciences in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kapil Dev MaharajSchool of Physics, Mathematics and Computing, The University of Western Australia, 35 Stirling Highway, Mailbag M013, Crawley, WA, 6009, Australia. 23018109@student.uwa.edu.au.ORCID http://orcid.org/0009-0008-6848-2372
Simon GoodallSchool of Physics, Mathematics and Computing, The University of Western Australia, 35 Stirling Highway, Mailbag M013, Crawley, WA, 6009, Australia.
Mahsheed SabetSchool of Physics, Mathematics and Computing, The University of Western Australia, 35 Stirling Highway, Mailbag M013, Crawley, WA, 6009, Australia.
Joshua DassDepartment Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Mounir IbrahimDepartment Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Talat MahmoodDepartment Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Pejman RowshanfarzadSchool of Physics, Mathematics and Computing, The University of Western Australia, 35 Stirling Highway, Mailbag M013, Crawley, WA, 6009, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy is an essential component of cancer treatment, but healthy tissues can be exposed to out-of-field doses, potentially causing adverse effects and secondary cancers. This study investigates peripheral doses outside the electron beam applicator in an Elekta Versa HD linear accelerator. Peripheral doses outside an electron applicator were measured using 6, 9, and 12 MeV beams at their respective maximum dose depths while maintaining a 100 cm source-to-surface distance. Measurements employed EBT3 films within Plastic Water DT phantoms. The influence of field size on penumbra width and peripheral doses were examined using various cutouts (6 × 6 cm², 10 × 10 cm², and a 5 cm diameter circle) within a 10 × 10 cm² applicator, with gantry and collimator angles set to 0 degrees. Additionally, the impact of collimator angles on penumbra width and peripheral doses was explored, enhancing the understanding of dose distribution. Measured profiles were also compared with those calculated using Monaco treatment planning system. Findings showed that both penumbra width and peripheral dose values increased with energy across different field sizes and collimator angles. Root Mean Square Deviation (RMSD) analysis indicated deviations of 1.8 mm for penumbra and 1.1% for peripheral doses between measured profiles and Treatment Planning System (TPS) predictions for all field sizes. Peripheral doses remained below 5% of the maximum dose at distances ranging from 10 to 15 mm away from the field edges, indicating acceptable tolerance levels (ICRU report 24). However, further dose reduction may be possible with additional shielding to keep doses as low as reasonably achievable. This study highlights the critical importance of considering peripheral doses in radiotherapy, emphasizing the need to evaluate the impact on healthy tissues outside the primary treatment area to ensure patient safety and mitigate long-term treatment-related side effects. The findings underscore the necessity of implementing appropriate measures to minimize peripheral doses.

Indexed as

ElectronsParticle AcceleratorsHumansPhantoms, ImagingRadiotherapy DosageRadiotherapy Planning, Computer-AssistedApplicatorElectron therapyElekta versa HDLinacOut-of-fieldPeripheral dose

Identifiers

PMID40100569
PMCPMC12209012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.